INS and diabetes mellitus: DM, a chronic metabolic noncommunicable disease, has attained epidemic proportions worldwide and the existing oral drugs for DM include biguanides, sulfonylureas, α-Glu inhibitors, etc. Among them, metformin can inhibit hepatic gluconeogenesis and promote the uptake and utilization of glucose by peripheral tissues, thereby improving the body’s insulin sensitivity.